Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avidity Biosciences, Inc.

26.57
-1.5300-5.44%
Post-market: 26.570.00000.00%19:18 EDT
Volume:1.84M
Turnover:49.36M
Market Cap:3.19B
PE:-9.20
High:27.83
Open:26.93
Low:26.23
Close:28.10
Loading ...
Jun 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 12, 2024

Major Issues Report

Form 8-K - Current report
Jun 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2024

Major Issues Report

Form 8-K - Current report
May 06, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2024

Major Issues Report

Form 8-K - Current report
Mar 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 01, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 29, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 29, 2024

Major Issues Report

Form 8-K - Current report